Disclosed positions

Estimated from their latest filings — positions may have changed since

$47.5K

combined est. value

Stock	Shares	Price	Value	Weight	As of
CHRSCoherus Oncology, Inc.	30,000	$1.59	$47.5K	100%	2026-06-05

CHRS

Coherus Oncology, Inc.

$47.5K

30,000 sh

All filings on record

Every Form 4 transaction we track for this filer

all 1buys 0sells 0

Stock	Transaction	Date	~6mo later
CHRSCoherus Oncology, Inc.	Grant — · 30,000 sh	2026-06-05	—

CHRSGrant

2026-06-05 · Coherus Oncology, Inc.

30,000

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.